Trials / Completed
CompletedNCT02480348
Medtronic RevElution Trial
Medtronic Polymer-Free Drug-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 109 (actual)
- Sponsor
- Medtronic Vascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to evaluate the clinical safety and efficacy of the Polymer-Free Drug-Eluting coronary stent system for the treatment of de novo lesions in native coronary arteries with a reference vessel diameter (RVD) that allows use of stents between 2.25 and 3.50 mm in diameter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Polymer-free DES (Drug Eluting Stent) |
Timeline
- Start date
- 2015-12-03
- Primary completion
- 2017-06-16
- Completion
- 2019-10-21
- First posted
- 2015-06-24
- Last updated
- 2020-07-07
Locations
15 sites across 3 countries: Australia, Brazil, Singapore
Source: ClinicalTrials.gov record NCT02480348. Inclusion in this directory is not an endorsement.